Presenter Status

Fellow

Abstract Type

Research

Primary Mentor

Jason D. Fraser, MD

Start Date

10-5-2021 11:30 AM

End Date

10-5-2021 1:30 PM

Presentation Type

Poster Presentation

Description

Background: We previously reported treatment and outcomes of children with untreated, not spontaneously draining (UTND) breast abscesses. What has not been well defined however are those with previously treated, not spontaneously draining (PTND) pediatric breast abscesses. In general, a more conservative approach is favored in children with breast abscesses to avoid damage to the developing breast bud.

Objectives/Goal: We sought to determine if care at a pediatric tertiary referral center impacts disease persistence rate.

Methods/Design: Following IRB approval, patientstherapy.

Results: In all, 114 patients met inclusion criteria, 96 in the UTND group and 18 in the PTND group (Figure 1). Baseline demographics, including abscess size, were similar. Patients previously treated at other hospitals (OSH) were more likely to use antibiotics alone as primary therapy compared to more invasive measures, like incision and drainage and needle aspiration (100% vs. 47%, p=

Conclusions: Antibiotic therapy, when properly chosen, remains a safe first-line treatment of pediatric breast abscesses.

MeSH Keywords

Abscess; Clindamycin; Trimethoprim, Sulfamethoxazole Drug Combination; Anti-bacterial Agents; tertiary care center; drainage; treatment outcome; breast

Share

COinS
 
May 10th, 11:30 AM May 10th, 1:30 PM

Refining the Optimal First Treatment for Pediatric Breast Abscesses

Background: We previously reported treatment and outcomes of children with untreated, not spontaneously draining (UTND) breast abscesses. What has not been well defined however are those with previously treated, not spontaneously draining (PTND) pediatric breast abscesses. In general, a more conservative approach is favored in children with breast abscesses to avoid damage to the developing breast bud.

Objectives/Goal: We sought to determine if care at a pediatric tertiary referral center impacts disease persistence rate.

Methods/Design: Following IRB approval, patientstherapy.

Results: In all, 114 patients met inclusion criteria, 96 in the UTND group and 18 in the PTND group (Figure 1). Baseline demographics, including abscess size, were similar. Patients previously treated at other hospitals (OSH) were more likely to use antibiotics alone as primary therapy compared to more invasive measures, like incision and drainage and needle aspiration (100% vs. 47%, p=

Conclusions: Antibiotic therapy, when properly chosen, remains a safe first-line treatment of pediatric breast abscesses.